Search Results 221-230 of 17794 for Coagulate
Uncorrectable abnormal coagulation parameters (platelet count ≤75000/mm3; INR ≥2.0 or fibrinogen ≤1.5 g/l); Active systemic infection requiring treatment ...
Participation eligibility · Females · At least 18 years of age · “Index” patients with at least one documented visit to the Mayo Rochester Coagulation Clinic ...
Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects; Acquired Immune Deficiency Syndrome (AIDS) based upon current Centers for ...
Subject has clinical evidence of pulmonary leukostasis and disseminated intravascular coagulation. Subject has known chronic obstructive pulmonary disease ...
- Certain comorbidities: coagulation/bleeding disorders, diminished capacity from cardiac/pulmonary disease - Obtaining another interventional procedure ...
Clinically significant intravascular coagulation. Treatment with other investigational drugs within 14 days prior to first study treatment administration ...
Inability to hold use of anti-coagulation medications or non-aspirin anti-platelet agents (APAs) for the duration recommended per ASGE guidelines for a high- ...
Adequate hematologic, renal, hepatic, and coagulation function; Negative serum pregnancy test for female subjects with reproductive potential, and agreement ...
It is used to treat moderate to severe hot flashes, changes in and around the vagina, and other symptoms of menopause or low amounts of estrogen ( ...
Abnormal bleeding history or coagulation profile (INR >1.5). Prior history of adverse events with conscious sedation. Participating Mayo Clinic locations.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.